Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

Who May Qualify: - Patients with symptomatic aortic stenosis/regurgitation - Subject has been informed of the nature of the study, agrees to its provisions and has provided written willing to sign a consent form. - The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed. - Patients are technical and anatomical eligible for interventions Who Should NOT Join This Trial: - A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media - Subject refuses a blood transfusion. - Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent. - Life expectancy is less than one year Always talk to your doctor about whether this trial is right for you.